CIP
CNCE

Convergence Investment Partners’s Concert Pharmaceuticals, Inc. CNCE Stock Holding History

Convergence Investment Partners’s Portfolio CNCE Stock Details CNCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-27,750
Closed -$718K – 1074
2017
Q4 		$718K Buy
+27,750
New +$718K 0.1% 258